BACKGROUND: Hip resurfacing arthroplasty is a common procedure that improves functional scores and has a reported survivorship between 95% and 98% at 5 years. However, most studies are reported from the pioneering rather than independent centers or have relatively small patient numbers or less than five years followup. Various factors have been implicated in early failure. QUESTIONS/PURPOSES: Our purposes were to determine: (1) the midterm survival of the BHR; (2) the function in patients treated with hip resurfacing; and (3) whether age, gender, BMI, or size of components related to failure. METHODS: We reviewed the first 302 patients (329 hips) on whom we performed resurfacing arthroplasty. We assessed the survivorship, change in functional hip scores (HHS, OHS, WOMAC, UCLA), and analyzed potential risk factors (age, gender, BMI, component size) for failure. The mean age at the time of surgery was 56.0 years (range, 28.2-75.5 years). The minimum followup was 5 years (mean, 6.6 years; range, 5-9.2 years). RESULTS: Kaplan-Meier analysis showed survival of 96.5% (95% CI, 94.7-98.4) at 9 years taking revision for any cause as the endpoint. All functional hip scores (HHS, OHS, WOMAC, UCLA) improved. Survivorship was higher in men compared with women. The component sizes and body mass index were smaller in the revised group compared with the nonrevised group. CONCLUSIONS: Medium-term survivorship and functional scores of hip resurfacing are comparable to those from the pioneering center. Hip resurfacing remains a good alternative to THA, particularly in the younger male population with relatively large femoral head sizes.
BACKGROUND: Hip resurfacing arthroplasty is a common procedure that improves functional scores and has a reported survivorship between 95% and 98% at 5 years. However, most studies are reported from the pioneering rather than independent centers or have relatively small patient numbers or less than five years followup. Various factors have been implicated in early failure. QUESTIONS/PURPOSES: Our purposes were to determine: (1) the midterm survival of the BHR; (2) the function in patients treated with hip resurfacing; and (3) whether age, gender, BMI, or size of components related to failure. METHODS: We reviewed the first 302 patients (329 hips) on whom we performed resurfacing arthroplasty. We assessed the survivorship, change in functional hip scores (HHS, OHS, WOMAC, UCLA), and analyzed potential risk factors (age, gender, BMI, component size) for failure. The mean age at the time of surgery was 56.0 years (range, 28.2-75.5 years). The minimum followup was 5 years (mean, 6.6 years; range, 5-9.2 years). RESULTS: Kaplan-Meier analysis showed survival of 96.5% (95% CI, 94.7-98.4) at 9 years taking revision for any cause as the endpoint. All functional hip scores (HHS, OHS, WOMAC, UCLA) improved. Survivorship was higher in men compared with women. The component sizes and body mass index were smaller in the revised group compared with the nonrevised group. CONCLUSIONS: Medium-term survivorship and functional scores of hip resurfacing are comparable to those from the pioneering center. Hip resurfacing remains a good alternative to THA, particularly in the younger male population with relatively large femoral head sizes.
Authors: H McKellop; S H Park; R Chiesa; P Doorn; B Lu; P Normand; P Grigoris; H Amstutz Journal: Clin Orthop Relat Res Date: 1996-08 Impact factor: 4.176
Authors: Michael A Mont; Thorsten M Seyler; David R Marker; German A Marulanda; Ronald E Delanois Journal: J Bone Joint Surg Am Date: 2006-11 Impact factor: 5.284
Authors: Harlan C Amstutz; Paul E Beaulé; Frederick J Dorey; Michel J Le Duff; Pat A Campbell; Thomas A Gruen Journal: J Bone Joint Surg Am Date: 2004-01 Impact factor: 5.284
Authors: Robert-Tobias Steffen; Pedro R Foguet; Stephen J Krikler; Roger Gundle; David J Beard; David W Murray Journal: J Arthroplasty Date: 2008-06-13 Impact factor: 4.757
Authors: Wael A Rahman; Nelson V Greidanus; Alexander Siegmeth; Bassam A Masri; Clive P Duncan; Donald S Garbuz Journal: Clin Orthop Relat Res Date: 2013-02 Impact factor: 4.176
Authors: Bruno Gomes; Michael Olsen; Michael Donnelly; Ashesh Kumar; Emil H Schemitsch Journal: Clin Orthop Relat Res Date: 2013-02 Impact factor: 4.176
Authors: Deborah A Marshall; Karen Pykerman; Jason Werle; Diane Lorenzetti; Tracy Wasylak; Tom Noseworthy; Donald A Dick; Greg O'Connor; Aish Sundaram; Sanne Heintzbergen; Cy Frank Journal: Clin Orthop Relat Res Date: 2014-04-04 Impact factor: 4.176
Authors: James Stoney; Stephen E Graves; Richard N de Steiger; Sophia Rainbird; Thu-Lan Kelly; Alesha Hatton Journal: Clin Orthop Relat Res Date: 2020-11 Impact factor: 4.755